Trials / Completed
CompletedNCT03132194
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris
A Single-center, Double-blind, Randomized, Parallel-group Study, Comparing DPSG to a Placebo Control in the Treatment of Acne Vulgaris
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 1,125 (actual)
- Sponsor
- Sun Pharmaceutical Industries, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the therapeutic effect of DPSG and Placebo gel in the treatment of acne vulgaris.
Detailed description
A Multi-center, Double-Blind, Randomized, Placebo Controlled, Parallel-Group study comparing DPSG to ACZONE Gel and active treatment to a Placebo control in the treatment of Acne Vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DPSG 7.5% | topical gel |
| DRUG | Aczone | topical gel |
| DRUG | Placebo | topical gel |
Timeline
- Start date
- 2016-08-08
- Primary completion
- 2017-01-16
- Completion
- 2017-01-30
- First posted
- 2017-04-27
- Last updated
- 2017-05-04
Source: ClinicalTrials.gov record NCT03132194. Inclusion in this directory is not an endorsement.